RAD51 and invasive breast carcinoma: Functional assays showed that these miRNAs exerted antitumor functions in BrCa cells by controlling several genes closely involved in BrCa malignant transformation, e.g., TRIP13, CCNB1, RAD51, PSPH, CENPN, KPNA2, and MXRA5.